Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jade Ghosn

Showing results (171-180 of 267) with videos related to

Pageof 27
Sort By:
The Journal of Antimicrobial Chemotherapy|January 20, 2023
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055Antoine Bachelard, Valentina Isernia, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 resultsAlexandra Serris, Valentine Marie Ferre, Quentin Le Hingrat, et al.
Sexually Transmitted Infections|October 24, 2025
Willingness to participate in a long-acting injectable cabotegravir HIV pre-exposure prophylaxis study among men who have sex with men in the French ANRS-PREVENIR cohortAugust Eubanks, Maxime Hoyer, Abdourahmane Sow, et al.
Idcases|September 6, 2021
Cholangitis in three critically ill patients after a severe CoVID-19 infectionCyrille Gourjault, Hassan Tarhini, Mayda Rahi, et al.
AIDS (London, England)|September 16, 2015
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapyLise Cuzin, Pascal Pugliese, Karine Sauné, et al.
Nature Communications|August 10, 2021
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patientsMatthieu Perreau, Madeleine Suffiotti, Pedro Marques-Vidal, et al.
Sexually Transmitted Infections|August 5, 2025
Pre-exposure prophylaxis (PrEP) uptake and retention in care in a group of transgender women at high risk of HIV: a French cohort of follow-upValentina Isernia, Minerva Cervantes, Marc Digumber, et al.
Journal of Medical Virology|November 27, 2023
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patientsHoussem Redha Chenane, Guillaume Lingas, Reyene Menidjel, et al.
The Lancet Regional Health. Europe|August 27, 2024
Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trialJade Ghosn, Lambert Assoumou, Moussa Ouattara, et al.
Open Forum Infectious Diseases|June 22, 2026
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program <sup>a</sup>Constance Delaugerre, Sarah Mafi, Arbnor Zenuni, et al.
Pageof 27

Showing results (171-180 of 267) with videos related to

Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|January 20, 2023
Same-day initiation of bictegravir/emtricitabine/tenofovir alafenamide: Week 48 results of the FAST study-IMEA 055Antoine Bachelard, Valentina Isernia, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 resultsAlexandra Serris, Valentine Marie Ferre, Quentin Le Hingrat, et al.
Sexually Transmitted Infections|October 24, 2025
Willingness to participate in a long-acting injectable cabotegravir HIV pre-exposure prophylaxis study among men who have sex with men in the French ANRS-PREVENIR cohortAugust Eubanks, Maxime Hoyer, Abdourahmane Sow, et al.
Idcases|September 6, 2021
Cholangitis in three critically ill patients after a severe CoVID-19 infectionCyrille Gourjault, Hassan Tarhini, Mayda Rahi, et al.
AIDS (London, England)|September 16, 2015
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapyLise Cuzin, Pascal Pugliese, Karine Sauné, et al.
Nature Communications|August 10, 2021
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patientsMatthieu Perreau, Madeleine Suffiotti, Pedro Marques-Vidal, et al.
Sexually Transmitted Infections|August 5, 2025
Pre-exposure prophylaxis (PrEP) uptake and retention in care in a group of transgender women at high risk of HIV: a French cohort of follow-upValentina Isernia, Minerva Cervantes, Marc Digumber, et al.
Journal of Medical Virology|November 27, 2023
High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patientsHoussem Redha Chenane, Guillaume Lingas, Reyene Menidjel, et al.
The Lancet Regional Health. Europe|August 27, 2024
Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trialJade Ghosn, Lambert Assoumou, Moussa Ouattara, et al.
Open Forum Infectious Diseases|June 22, 2026
Effectiveness and Safety of Lenacapavir-Containing Regimens in Highly Experienced HIV-Infected Patients With Multidrug Resistance: Real-world Results From the French Compassionate Use Program <sup>a</sup>Constance Delaugerre, Sarah Mafi, Arbnor Zenuni, et al.
Pageof 27